down arrow

Danimer Scientific, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US2362721001
USD
0.02
0.00 (0.00%)

Jul 25

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.020.15

52 Week

0.0220.00
Valuation
Technical
Day's Volume

CASH

12.72 k

Shareholding (Sep 2024)

FII

5.77%

Held by 46 FIIs

DII

80.48%

Held by 14 DIIs

Promoter

0.00%

How big is Danimer Scientific, Inc.?

22-Jun-2025

As of Jun 18, Danimer Scientific, Inc. has a market capitalization of 0.79 million, with net sales of 37.43 million and a net profit loss of 111.19 million over the last four quarters. Shareholder's funds total 278.02 million, and total assets are reported at 730.28 million.

Market Cap: As of Jun 18, Danimer Scientific, Inc. has a market capitalization of 0.79 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Danimer Scientific reported net sales of 37.43 million. However, the company experienced a net profit loss of 111.19 million during the same period.<BR><BR>Balance Sheet Snapshot: As of Dec 23, the shareholder's funds for Danimer Scientific amounted to 278.02 million, while total assets were reported at 730.28 million.

Read More

What does Danimer Scientific, Inc. do?

22-Jun-2025

Danimer Scientific, Inc. is a micro-cap company in the specialty chemicals industry, reporting net sales of $9 million and a net loss of $22 million as of September 2024. The company has a market cap of $0.79 million and key metrics indicate it is currently loss-making with a debt-to-equity ratio of 1.75.

Overview:<BR>Danimer Scientific, Inc. operates in the specialty chemicals industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 9 Million (Quarterly Results - Sep 2024) <BR>Most recent Net Profit: -22 Million (Quarterly Results - Sep 2024) <BR>Market-cap: USD 0.79 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 1.75 <BR>Return on Equity: -58.40% <BR>Price to Book: 0.00 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Danimer Scientific, Inc. overvalued or undervalued?

25-Jun-2025

As of August 9, 2022, Danimer Scientific, Inc. is considered overvalued and risky due to poor financial ratios and a year-to-date return of -89.76%, significantly underperforming compared to its peers and the S&P 500.

As of 9 August 2022, the valuation grade for Danimer Scientific, Inc. moved from fair to risky, indicating a significant deterioration in its financial outlook. The company is currently assessed as overvalued, particularly given its troubling financial ratios, including a Price to Book Value of 0.00, an EV to EBITDA of -6.48, and a ROE of -58.40%. These figures suggest that the company is struggling to generate returns and is not effectively utilizing its capital.<BR><BR>In comparison to its peers, Danimer's financial metrics are concerning. For instance, Proto Labs, Inc. is classified as expensive with a P/E ratio of 44.27, while Valhi, Inc. stands out as very attractive with an EV to EBITDA of 2.94. The stark contrast in valuation between Danimer and its peers highlights its precarious position in the market. Additionally, Danimer's stock has significantly underperformed against the S&P 500, with a year-to-date return of -89.76%, reinforcing the notion that it is overvalued in the current market context.

Read More

Is Danimer Scientific, Inc. technically bullish or bearish?

20-Sep-2025

As of June 27, 2025, Danimer Scientific, Inc. shows a mildly bearish trend, influenced by bearish moving averages and Dow Theory signals, despite some mildly bullish indicators, and has significantly underperformed the S&P 500 with a year-to-date return of -99.05%.

As of 27 June 2025, the technical trend for Danimer Scientific, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a bearish daily moving average and bearish signals from the Dow Theory on both weekly and monthly time frames. However, the weekly MACD and KST indicators are mildly bullish, suggesting some potential for upward movement. The stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -99.05% versus the S&P's 12.22%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 0 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.75

stock-summary
Return on Equity

-58.40%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
9 Million
(Quarterly Results - Sep 2024)
Net Profit:
-22 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-94.87%
0%
-94.87%
6 Months
-98.86%
0%
-98.86%
1 Year
-99.91%
0%
-99.91%
2 Years
-99.29%
0%
-99.29%
3 Years
-99.99%
0%
-99.99%
4 Years
-100.0%
0%
-100.0%
5 Years
-99.99%
0%
-99.99%

Danimer Scientific, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Danimer Scientific, Inc. technically bullish or bearish?

As of 27 June 2025, the technical trend for Danimer Scientific, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a bearish daily moving average and bearish signals from the Dow Theory on both weekly and monthly time frames. However, the weekly MACD and KST indicators are mildly bullish, suggesting some potential for upward movement. The stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -99.05% versus the S&P's 12.22%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
148.98%
EBIT Growth (5y)
-404.14%
EBIT to Interest (avg)
-26.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.75
Sales to Capital Employed (avg)
0.07
Tax Ratio
0.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
41.25%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.00
EV to EBIT
-4.26
EV to EBITDA
-6.48
EV to Capital Employed
0.64
EV to Sales
9.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.95%
ROE (Latest)
-58.40%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 25 Schemes (13.75%)

Foreign Institutions

Held by 46 Foreign Institutions (5.77%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is 13.16% vs -25.49% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is 3.96% vs 16.85% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.60",
          "val2": "7.60",
          "chgp": "13.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.40",
          "val2": "-11.30",
          "chgp": "-0.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.60",
          "val2": "9.10",
          "chgp": "5.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.60",
          "val2": "5.70",
          "chgp": "15.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-21.80",
          "val2": "-22.70",
          "chgp": "3.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,173.30%",
          "val2": "-2,459.90%",
          "chgp": "28.66%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -12.22% vs -9.37% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 13.52% vs -199.17% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "46.70",
          "val2": "53.20",
          "chgp": "-12.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-96.10",
          "val2": "-103.90",
          "chgp": "7.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "29.60",
          "val2": "1.70",
          "chgp": "1,641.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-55.60",
          "chgp": "99.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-155.50",
          "val2": "-179.80",
          "chgp": "13.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,681.50%",
          "val2": "-2,328.90%",
          "chgp": "-35.26%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQstock-summary
Sep'24
Jun'24
Change(%)
Net Sales
8.60
7.60
13.16%
Operating Profit (PBDIT) excl Other Income
-11.40
-11.30
-0.88%
Interest
9.60
9.10
5.49%
Exceptional Items
6.60
5.70
15.79%
Consolidate Net Profit
-21.80
-22.70
3.96%
Operating Profit Margin (Excl OI)
-2,173.30%
-2,459.90%
28.66%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2024 is 13.16% vs -25.49% in Jun 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2024 is 3.96% vs 16.85% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
46.70
53.20
-12.22%
Operating Profit (PBDIT) excl Other Income
-96.10
-103.90
7.51%
Interest
29.60
1.70
1,641.18%
Exceptional Items
-0.10
-55.60
99.82%
Consolidate Net Profit
-155.50
-179.80
13.52%
Operating Profit Margin (Excl OI)
-2,681.50%
-2,328.90%
-35.26%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -12.22% vs -9.37% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 13.52% vs -199.17% in Dec 2022

All Annual Resultsstock-summary
stock-summaryCompany CV
About Danimer Scientific, Inc. stock-summary
stock-summary
Danimer Scientific, Inc.
Specialty Chemicals
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."